Renal Dosimetry in Peptide Radionuclide Receptor Therapy-Reference-Cited by-同舟云学术

Renal Dosimetry in Peptide Radionuclide Receptor Therapy

Published:2010-10 Issue:5 Volume:25 Page:581-588
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Siegel Jeffry A.¹,Stabin Michael G.²,Sharkey Robert M.³

Affiliation:

1. Nuclear Physics Enterprises, Marlton, New Jersey.

2. Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee.

3. Center for Molecular Medicine and Immunology, Garden State Cancer Center, Belleville, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2010.0805

Reference33 articles.

1. Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues

2. PHYSICAL MODELS AND DOSE FACTORS FOR USE IN INTERNAL DOSE ASSESSMENT

3. The comparison of treatment plans

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy;Journal of Nuclear Medicine;2018-03-09

2. Sensitivity Analysis of a Physiologically Based Pharmacokinetic Model Used for Treatment Planning in Peptide Receptor Radionuclide Therapy;Cancer Biotherapy and Radiopharmaceuticals;2016-08

3. Patient-specific dosimetry in peptide receptor radionuclide therapy: a clinical review;Australasian Physical & Engineering Sciences in Medicine;2014-11-27

4. Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment;Journal of Nuclear Medicine;2012-12-07

5. 4D SPECT/CT Acquisition for 3D Dose Calculation and Dose Planning in 177Lu-Peptide Receptor Radionuclide Therapy: Applications for Clinical Routine;Recent Results in Cancer Research;2012-08-24